Table 3

From: Modeling medulloblastoma in vivo and with human cerebellar organoids

Target Gene

Forward primer

Reverse primer

CCND1

ATGTTCGTGGCCTCTAAGATGA

CAGGTTCCACTTGAGCTTGTTC

CDK4

CTTTGGCAGCTGGTCACATGG

CTCAGATCAAGGGAGACCCTCAC

P21

CTGGAGACTCTCAGGGTCGAA

GATTAGGGCTTCCTCTTGGAGAA

CDKN2B (p15)

CCCTCGACACTCACCATGAA

CGACCCCTGGAATGTCACAC

GAPDH

CCACTCCTCCACCTTTGAC

ACCCTGTTGCTGTAGCCA

CCNB1

ATGTGCCCCTGCAGAAGAAG

TTTCCAGTGACTTCCCGACC

GAS1

GGACGAGAACTGCAAGTCCA

AGACTTTGCCGCAGTAGGTC

hsa-miR9-2

CTAACGCTGCCGGAGATTAC

TACTTGCCGCGCTTAAGATT

hsa-miR9-3

GCGCTCGAGGCTCTCTAAG

GAGGGGATGGACAGACACAC

CDH2 (N-cadherin)

CGACGAATGGATGAAAGACCC

GCCACTGCCTTCATAGTCAAAC

SNAI1

CTAGGCCCTGGCTGCTACAA

CCTGGCACTGGTACTTCTTGA

TWIST1

CTTCTCGGTCTGGAGGATGG

GAAACAATGACATCTAGGTCTCCG

PRUNE1

CACTGAGCAGATGCTGAGAAAAG

TGCACTAATGGCCACCTTGAC

PIN1

GAGAAGATCACCCGGACCAA

AAAGTCCTCCTCTCCCGACT

NRL

CATTGGGGCTGAGTCCTGAA

CGCACAGACATCGAGACCA

CRX

CCCACTATTCTGTCAACGCCT

GACGTCTGGGTACTGGGTCT

CCND2

GCGGAGAAGCTGTGCATTTA

CATGCTTGCGGATCAGAGAC

BCL2L1 (BCL-XL)

CTGTGCGTGGAAAGCGTAGA

GCTGCTGCATTGTTCCCATAG

NCAM

GAGATCAGCGTTGGAGAGTCC

GGAGAACCAGGAGATGTCTTTATCTT

PTPRZ1 (DSD-1-PG)

TGCAGAGCTGTACTGTTGACTT

CTGTGCTAGCTTAACCCTGCT

EFNA2 (Ephrin A2)

CTACATCTCTGCCACGCCTC

CGGGCTGCTACACGAGTTAT

TNC (Tenascin-C)

TCTGGTGCTGAACGAACTGC

CCAGGAAACTGTGAACCCGTA

XBP1

TGCCAGAGATCGAAAGAAGGC

CCAAGCGCTGTCTTAACTCCT

KIT

CCTGAACACCAGCAGTGGAT

TGTAAGTGCCTCCTTCGGTG

TYRO3

GCCACTGGTGGTCTCTTCTC

CGTTAGCACACCAAGGACCA

CDKN2A (p16)

CTTCGGCTGACTGGCTGG

CGTGTCCAGGAAGCCCTC

CRABP1

ACTTCAAGGTCGGAGAAGGC

AGTTTGCGTGCAGTGGATCT

BMI-1

CGCTTGGCTCGCATTCATTT

CACACACATCAGGTGGGGAT

DLGAP5 (HURP)

TGTTTGGTTGAGGTTTCACGC

CCTGTGTCGACTGGCAAAATG

AURKA

CAGTACATGCTCCATCTTCCAG

AAAGAACTCCAAGGCTCCAG

cMyc

GCGACTCTGAGGAGGAACAA

CCTCCAGCAGAAGGTGATCC

OTX2

GAGGTGGCACTGAAAATCAAC

TCTTCTTTTTGGCAGGTCTCA

SMARCA4

TGCTCCGACGACTCAAGAAG

TTCATCAGGGTCTTGGTGCC

SMARCA4-FLAG

GAAGGAGAAGGCACAGGACC

TCATCGTCGTCCTTGTAGTCG

SMARCA4-Venus

GAAGGAGAAGGCACAGGACC

CACCACCCCGGTGAACAG